Discovery of Highly Isoform Selective Orally Bioavailable Phosphoinositide 3-Kinase (PI3K)-γ Inhibitors

Pemberton, N, Mogemark, M, Arlbrandt, S , Bold, P, Cox, RJ, Gardelli, C, Holden, Neil, Karabelas, K, Karlsson, J, Lever, J, Li, X, Lindmark, H, Norberg, M, Perry, MWD, Petersen, J, Rodrigo Blomqvist, S, Thomas, M, Tyrchan, C, Westin Eriksson, A, Zlatoidsky, P and Öster, L (2018) Discovery of Highly Isoform Selective Orally Bioavailable Phosphoinositide 3-Kinase (PI3K)-γ Inhibitors. Journal of Medical Chemistry, 61 (12). pp. 5435-5441. ISSN 0022-2623

Full content URL: http://doi.org/10.1021/acs.jmedchem.8b00447

Documents
Discovery of Highly Isoform Selective Orally Bioavailable Phosphoinositide 3-Kinase (PI3K)-γ Inhibitors
[img]
[Download]
[img] PDF
acs.jmedchem.8b00447.pdf - Whole Document

1MB
Item Type:Article
Item Status:Live Archive

Abstract

In this paper, we describe the discovery and optimization of a new chemotype of isoform selective PI3Kγ inhibitors. Starting from an HTS hit, potency and physicochemical properties could be improved to give compounds such as 15, which is a potent and remarkably selective PI3Kγ inhibitor with ADME properties suitable for oral administration. Compound 15 was advanced into in vivo studies showing dose-dependent inhibition of LPS-induced airway neutrophilia in rats when administered orally.

Keywords:PI3K
Subjects:C Biological Sciences > C790 Molecular Biology, Biophysics and Biochemistry not elsewhere classified
Divisions:College of Science > School of Life Sciences
Related URLs:
ID Code:33955
Deposited On:13 Nov 2018 15:20

Repository Staff Only: item control page